Welcome to this UK AstraZeneca produced and funded website
This website is intended for UK Healthcare Professionals only.
The website contains both promotional and non-promotional content.
If you are a patient or a carer of a patient prescribed an AstraZeneca product, please visit myazmed.co.uk
For any other UK residents please visit astrazeneca.co.uk
This website is intended for UK Healthcare Professionals only. Other UK residents please visit astrazeneca.co.uk
These resources have been developed and funded by AstraZeneca and contain mentions of AstraZeneca’s products.
Connecting with the National Amyloidosis Centre (NAC), patient organisations and charities about ATTRv-PN can:
If you wish to order hard copy materials, please submit the form below:
Fields marked with * are mandatory. Your personal details will not be used for any promotional purposes without your explicit consent. More details can be found in our Privacy Policy.
Your request is being processed. The items selected will be delivered as soon as possible.
Please make sure the delivery point is expecting your support materials.
ATTR=transthyretin amyloidosis; ATTRv-PN=hereditary transthyretin amyloidosis with polyneuropathy; NHS=National Health Service; PSP=Patient Support Programme.
GB-62850 | November 2025
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling 0800 783 0033.
This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.
